Trial · NCT01496469
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in 24-hour Mean Systolic Blood Pressure (SBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 | Placebo | Baseline | 142.3 | Standard Error 1.21 | millimeters of mercury (mmHg) |
| Change From Baseline in 24-hour Mean Systolic Blood Pressure (SBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 | Febuxostat 80 mg | Baseline | 139.5 | Standard Error 1.18 | millimeters of mercury (mmHg) |
| Change From Baseline in 24-hour Mean Systolic Blood Pressure (SBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 | Placebo | Change at Week 6 | -3.4 | Standard Error 1.31 | millimeters of mercury (mmHg) |
| Change From Baseline in 24-hour Mean Systolic Blood Pressure (SBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 | Febuxostat 80 mg | Change at Week 6 | -3.7 | Standard Error 1.27 | millimeters of mercury (mmHg) |
| Change From Baseline in 24-hour Mean Diastolic Blood Pressure (DBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 | Placebo | Baseline | 85.9 | Standard Error 1.14 | mmHg |
| Change From Baseline in 24-hour Mean Diastolic Blood Pressure (DBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 | Febuxostat 80 mg | Baseline | 83.0 | Standard Error 1.11 | mmHg |
| Change From Baseline in 24-hour Mean Diastolic Blood Pressure (DBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 | Placebo | Change at Week 6 | -2.7 | Standard Error 0.91 | mmHg |
| Change From Baseline in 24-hour Mean Diastolic Blood Pressure (DBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 | Febuxostat 80 mg | Change at Week 6 | -2.0 | Standard Error 0.88 | mmHg |
| Change From Baseline in Serum Urate Levels at Week 6 | Placebo | Baseline | 7.7 | Standard Error 0.14 | mg/dL |
| Change From Baseline in Serum Urate Levels at Week 6 | Febuxostat 80 mg | Baseline | 7.6 | Standard Error 0.14 | mg/dL |
| Change From Baseline in Serum Urate Levels at Week 6 | Placebo | Change at Week 6 | 0.1 | Standard Error 0.17 | mg/dL |
| Change From Baseline in Serum Urate Levels at Week 6 | Febuxostat 80 mg | Change at Week 6 | -3.3 | Standard Error 0.17 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01496469/results